Ontology highlight
ABSTRACT: Introduction
Allogeneic iPSCs provide a potential source for regenerative T cell therapies, yet their clinical application remains limited by immune rejection driven by human leukocyte antigen (HLA) incompatibility. Knockout of β2-microglobulin (B2M) eliminates HLA class I expression and protects against CD8+ T cell-mediated killing, but paradoxically provokes natural killer (NK) cell activation via the "missing-self" response. Existing approaches seek to enhance inhibitory signaling or dampen activating signals, yet these approaches achieve only partial NK evasion due to the extraordinary heterogeneity of NK receptor repertoires.Methods
We developed a broader and more universal immune evasion strategy by targeting immune synapse (IS) adhesion molecules that crit
SUBMITTER: Zhang J
PROVIDER: S-EPMC12828601 | biostudies-literature | 2026 Mar
REPOSITORIES: biostudies-literature